Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11774527 | 0.77 | LMNA (0.43) | MIFTSHRLMNAMAPK1ALDH1A1 | |
| SCHEMBL2001199 | 0.76 | MIF (0.61) | MIFTSHRHIF1ATRPA1ALDH1A1 | |
| SCHEMBL1247431 | 0.76 | MIF (0.61) | MIFTSHRHIF1ATRPA1ALDH1A1 | |
| SCHEMBL5052780 | 0.73 | MIF (0.57) | MIFTSHRHIF1ATRPA1ALDH1A1 | |
| 1-Phenylethyl Isothiocyanate SCHEMBL3795180 | 0.73 | MIF (1.00) | MIFTSHRLMNAKDM4EADRA2A | |
| 1-Phenylethyl Isothiocyanate SCHEMBL156959 | 0.73 | MIF (1.00) | MIFTSHRLMNAKDM4EADRA2A | |
| 1-Phenylethyl Isothiocyanate SCHEMBL3792824 | 0.73 | MIF (1.00) | MIFTSHRLMNAKDM4EADRA2A | |
| SCHEMBL14000099 | 0.73 | MIF (0.57) | MIFLMNAKDM4EADRA2AADRA2C | |
| 1-Phenylethyl Isothiocyanate SCHEMBL27811213 | 0.73 | MIF (1.00) | MIFTSHRLMNAKDM4EADRA2A | |
| SCHEMBL27494985 | 0.73 | MIF (0.57) | MIFTSHRHIF1ATRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120611-A1 | A LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME | UNILEVER N.V. (NL) | 2009-11-25 | — | — | EP | claimed |
| WO-2008134071-A1 | MULTIMODAL ABUSE RESISTANT EXTENDED RELEASE FORMULATIONS | THERAQUEST BIOSCIENCES, INC. (US) | 2008-11-06 | — | — | WO | claimed |
| WO-2008098804-A1 | A LOW FAT CONSUMER PRODUCT COMPRISING A NATURAL PRESERVATIVE SYSTEM AND A METHOD FOR MAKING THE SAME | UNILEVER N.V. (NL) | 2008-08-21 | — | — | WO | claimed |
| WO-2008033351-A2 | MULTIMODAL ABUSE RESISTANT AND EXTENDED RELEASE FORMULATIONS | THERAQUEST BIOSCIENCES, INC. (US) | 2008-03-20 | — | — | WO | claimed |
| EP-1841320-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. Ltd. (IL) | 2007-10-10 | — | — | EP | claimed |
| WO-2006075330-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. LTD. (IL) | 2006-07-20 | — | — | WO | claimed |
| US-20230189800-A1 | NEMATODE CONTROL | UNIVERSITY OF IDAHO (US) | 2023-06-22 | — | — | US | disclosed |
| US-11602147-B2 | Nematode control | UNIVERSITY OF IDAHO (US) | 2023-03-14 | — | — | US | disclosed |
| US-20220354125-A1 | METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF | UNIVERSITY OF IDAHO (US) | 2022-11-10 | — | — | US | disclosed |
| US-11229210-B2 | Method for using mustard meal or an extract thereof | Univerity of Idaho (US) | 2022-01-25 | — | — | US | disclosed |
| CN-108130192-B | Method for extracting high-purity mustard essential oil from mustard seeds | 浙江舟山彩麟之食品有限公司 | 2021-07-06 | — | — | CN | disclosed |
| US-20200221710-A1 | METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF | UNIVERSITY OF IDAHO (US) | 2020-07-16 | — | — | US | disclosed |
| US-20200170246-A1 | NEMATODE CONTROL | UNIVERSITY OF IDAHO (US) | 2020-06-04 | — | — | US | disclosed |
| EP-1450824-A4 | PHARMACEUTICAL COMPOSITION | ELAN CORP PLC (IE) | 2005-09-28 | — | — | EP | disclosed |
| WO-2005032283-A1 | ISOTHIOCYANATE PRESERVATIVES AND METHODS OF THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | disclosed |
| JP-2005013179-A | FERMENTATION CONTROLLING AGENT | TAIYO KAGAKU CO LTD | 2005-01-20 | — | — | JP | disclosed |
| EP-1450824-A1 | PHARMACEUTICAL COMPOSITION | ELAN CORPORATION, Plc (IE) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003039561-A1 | PHARMACEUTICAL COMPOSITION | ELAN CORPORATION, PLC (IE) | 2003-05-15 | — | — | WO | disclosed |
| EP-1229805-A1 | Beverage products comprising a preservative system consisting of an isothiocyanate in combination with a sorbate and/or a benzoate | THE PROCTER & GAMBLE COMPANY (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001035769-A1 | PRODUCTS COMPRISING AN ISOTHIOCYANATE PRESERVATIVE SYSTEM AND METHODS OF THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200221710-A1 | METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF | NOTUM, SI, MGAM | MIF 616/4885TSHR 4821/4885LMNA 3137/4885 |
| US-20230189800-A1 | NEMATODE CONTROL | SNCA, NPEPPS, VHL | MIF 1360/4885TSHR 4223/4885LMNA 2712/4885 |
| US-20200170246-A1 | NEMATODE CONTROL | SNCA, NPEPPS, VHL | MIF 1360/4885TSHR 4223/4885LMNA 2712/4885 |
| US-11229210-B2 | Method for using mustard meal or an extract thereof | NOTUM, SI, MGAM | MIF 616/4885TSHR 4821/4885LMNA 3137/4885 |
| US-11602147-B2 | Nematode control | SNCA, NPEPPS, VHL | MIF 1360/4885TSHR 4223/4885LMNA 2712/4885 |
| US-20220354125-A1 | METHOD FOR USING MUSTARD MEAL OR AN EXTRACT THEREOF | NOTUM, SI, MGAM | MIF 616/4885TSHR 4821/4885LMNA 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.